Lyme Disease Treatment Failure: At Least 1 in 3 Patients Remain Ill
Lyme disease treatment failure is more common than often recognized. While guidelines have suggested that persistent symptoms are uncommon, a growing body of evidence shows that many patients remain ill despite standard antibiotic therapy. :contentReference[oaicite:0]{index=0}
The Infectious Diseases Society of America (IDSA) has stated that ongoing symptoms may reflect “the aches and pains of daily living” rather than active infection or coinfection. [1]
However, multiple studies describe treatment failure and long-term consequences that extend well beyond typical recovery.
Evidence of Lyme Disease Treatment Failure
A case series published in the New England Journal of Medicine described patients who remained ill for up to 14 years with Lyme encephalopathy and neuropathy despite antibiotic therapy.
- 34% of patients in a population-based cohort remained ill an average of 6.2 years after treatment [2]
- 62% of 215 patients in Westchester County remained ill an average of 3.2 years after treatment [3]
- 57% of adults with Lyme neuroborreliosis remained ill years after treatment [4]
- A meta-analysis of 504 patients found persistent fatigue, pain, and neurocognitive symptoms compared with controls [5]
Importantly, these persistent symptoms were distinct from fibromyalgia, chronic fatigue syndrome, and depression. [5]
Impact on Quality of Life
NIH-sponsored trials demonstrated that quality of life in these patients can be significantly impaired. In some cases, it was comparable to congestive heart failure, with pain levels similar to post-surgical patients and fatigue comparable to multiple sclerosis. [6–9]
Defining Post-Treatment Lyme Disease Syndrome (PTLDS)
To better characterize patients who do not recover, a case definition for post-treatment Lyme disease syndrome (PTLDS) was proposed. [1]
- Documented Lyme disease
- Initial improvement after treatment
- Persistent or relapsing fatigue, pain, or cognitive symptoms within 6 months
- Symptoms severe enough to impair daily functioning [1]
Persistent Symptoms Despite Early Treatment
A Johns Hopkins study examined patients treated early with a 3-week course of doxycycline.
At six months:
- 36% reported fatigue
- 20% reported widespread pain
- 45% reported neurocognitive difficulties [10]
Some patients required retreatment due to treatment failure, including those with worsening neurologic findings or expanding erythema migrans rash during therapy.
Role of Coinfections in Treatment Failure
Coinfections may contribute to Lyme disease treatment failure. Up to 40% of patients with Lyme disease may have concurrent Babesiosis. [11]
These infections can complicate illness and may require different treatment approaches.
Timing of Treatment Matters
Outcomes differ depending on when treatment is initiated. Patients in NIH trials had often been ill for years before treatment, with averages of 4.7 years in the Klempner trials and 9 years in the Fallon trials. [7,12]
Clinical Implications
The message that Lyme disease is always “easy to treat” and “quick to resolve” does not reflect the experience of many patients.
Lyme disease treatment failure highlights the need for individualized care, recognition of persistent symptoms, and consideration of coinfections.
Increasing numbers of clinicians recognize that a one-size-fits-all approach is not always sufficient to restore health.
References:
- Wormser GP et al. Clin Infect Dis, 2006.
- Shadick NA et al. Ann Intern Med, 1994.
- Asch ES et al. J Rheumatol, 1994.
- Dersch R et al. J Neurol, 2015.
- Cairns V, Godwin J. Int J Epidemiol, 2005.
- Klempner MS et al. N Engl J Med, 2001.
- Fallon BA et al. Neurology, 2008.
- Krupp LB et al. Neurology, 2003.
- Cameron DJ et al. Expert Rev Anti Infect Ther, 2014.
- Aucott JN et al. Qual Life Res, 2013.
- Diuk-Wasser MA et al. Trends Parasitol, 2015.
- Klempner MS. Vector Borne Zoonotic Dis, 2002.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
